Richard Eisenstadt
2021 - AYTU BIOPHARMA
In 2021, Richard Eisenstadt earned a total compensation of $782.9K as Former Chief Financial Officer, Secretary and Treasurer since April at AYTU BIOPHARMA.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Salary | $151,934 |
| Stock Awards | $455,947 |
| Total | $782,881 |
Eisenstadt received $455.9K in stock awards, accounting for 58% of the total pay in 2021.
Eisenstadt also received $175K in bonus and $151.9K in salary.
Rankings
In 2021, Richard Eisenstadt's compensation ranked 9,550th out of 12,415 executives tracked by ExecPay. In other words, Eisenstadt earned more than 23.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,550 out of 12,415 | 23rd |
Division Manufacturing | 4,235 out of 5,508 | 23rd |
Major group Chemicals And Allied Products | 1,876 out of 2,378 | 21st |
Industry group Drugs | 1,664 out of 2,099 | 21st |
Industry Pharmaceutical Preparations | 1,239 out of 1,549 | 20th |
Source: SEC filing on April 7, 2022.
Eisenstadt's colleagues
We found two more compensation records of executives who worked with Richard Eisenstadt at AYTU BIOPHARMA in 2021.
News
PharmAthene CEO Vipin Garg's 2022 pay rises 9% to $2.9M
August 16, 2023
PharmAthene CEO Vipin Garg's 2021 pay jumps 83% to $2.6M
August 16, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
Neos Therapeutics CEO Gerald McLaughlin's 2019 pay falls 56% to $1.4M
April 21, 2020
Neos Therapeutics CEO Gerald McLaughlin receives $3.2M in 2018
April 24, 2019